BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30085835)

  • 1. Diffusion Kurtosis Imaging Combined With DWI at 3-T MRI for Detection and Assessment of Aggressiveness of Prostate Cancer.
    Wang X; Tu N; Qin T; Xing F; Wang P; Wu G
    AJR Am J Roentgenol; 2018 Oct; 211(4):797-804. PubMed ID: 30085835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer aggressive prediction: preponderant diagnostic performances of intravoxel incoherent motion (IVIM) imaging and diffusion kurtosis imaging (DKI) beyond ADC at 3.0 T scanner with gleason score at final pathology.
    Shan Y; Chen X; Liu K; Zeng M; Zhou J
    Abdom Radiol (NY); 2019 Oct; 44(10):3441-3452. PubMed ID: 31144091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Performance of Monoexponential DWI Versus Diffusion Kurtosis Imaging in Prostate Cancer: A Systematic Review and Meta-Analysis.
    Si Y; Liu RB
    AJR Am J Roentgenol; 2018 Aug; 211(2):358-368. PubMed ID: 29812977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion Kurtosis Imaging Helps to Predict Upgrading in Biopsy-Proven Prostate Cancer With a Gleason Score of 6.
    Wu CJ; Zhang YD; Bao ML; Li H; Wang XN; Liu XS; Shi HB
    AJR Am J Roentgenol; 2017 Nov; 209(5):1081-1087. PubMed ID: 28834443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
    Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
    Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diagnostic performance between diffusion kurtosis imaging parameters and mono-exponential ADC for determination of clinically significant cancer in patients with prostate cancer.
    Park H; Kim SH; Lee Y; Son JH
    Abdom Radiol (NY); 2020 Dec; 45(12):4235-4243. PubMed ID: 32965517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histogram analysis in prostate cancer: a comparison of diffusion kurtosis imaging model versus monoexponential model.
    Jiang Y; Li C; Liu Y; Shi K; Zhang W; Liu M; Chen M
    Acta Radiol; 2020 Oct; 61(10):1431-1440. PubMed ID: 32008343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Diffusion Kurtosis Imaging Versus Diffusion Tensor Imaging in Discriminating Between Benign Tissue, Low and High Gleason Grade Prostate Cancer.
    Di Trani MG; Nezzo M; Caporale AS; De Feo R; Miano R; Mauriello A; Bove P; Manenti G; Capuani S
    Acad Radiol; 2019 Oct; 26(10):1328-1337. PubMed ID: 30545680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histogram analysis of diffusion kurtosis magnetic resonance imaging in differentiation of pathologic Gleason grade of prostate cancer.
    Wang Q; Li H; Yan X; Wu CJ; Liu XS; Shi HB; Zhang YD
    Urol Oncol; 2015 Aug; 33(8):337.e15-24. PubMed ID: 26048104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic evaluation of magnetization transfer and diffusion kurtosis imaging for prostate cancer detection in a re-biopsy population.
    Barrett T; McLean M; Priest AN; Lawrence EM; Patterson AJ; Koo BC; Patterson I; Warren AY; Doble A; Gnanapragasam VJ; Kastner C; Gallagher FA
    Eur Radiol; 2018 Aug; 28(8):3141-3150. PubMed ID: 29222677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.
    Hötker AM; Mazaheri Y; Aras Ö; Zheng J; Moskowitz CS; Gondo T; Matsumoto K; Hricak H; Akin O
    AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of diffusion-kurtosis imaging for grading endometrial carcinoma: a comparative study with diffusion-weighted imaging.
    Chen T; Li Y; Lu SS; Zhang YD; Wang XN; Luo CY; Shi HB
    Clin Radiol; 2017 Nov; 72(11):995.e11-995.e20. PubMed ID: 28774471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Gaussian water diffusion kurtosis imaging of prostate cancer.
    Suo S; Chen X; Wu L; Zhang X; Yao Q; Fan Y; Wang H; Xu J
    Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New RESOLVE-Based Diffusional Kurtosis Imaging in MRI-Visible Prostate Cancer: Effect of Reduced b Value on Image Quality and Diagnostic Effectiveness.
    Zhang YD; Wu CJ; Bao ML; Li H; Yan X; Liu XS; Shi HB
    AJR Am J Roentgenol; 2016 Aug; 207(2):330-8. PubMed ID: 27187062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification.
    Pesapane F; Patella F; Fumarola EM; Panella S; Ierardi AM; Pompili GG; Franceschelli G; Angileri SA; Magenta Biasina A; Carrafiello G
    Med Oncol; 2017 Mar; 34(3):35. PubMed ID: 28144814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.
    Li C; Chen M; Wan B; Yu J; Liu M; Zhang W; Wang J
    Acta Radiol; 2018 Nov; 59(11):1395-1402. PubMed ID: 29486596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
    Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
    AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
    [No Abstract]   [Full Text] [Related]  

  • 20. Advanced Diffusion-weighted Imaging Modeling for Prostate Cancer Characterization: Correlation with Quantitative Histopathologic Tumor Tissue Composition-A Hypothesis-generating Study.
    Hectors SJ; Semaan S; Song C; Lewis S; Haines GK; Tewari A; Rastinehad AR; Taouli B
    Radiology; 2018 Mar; 286(3):918-928. PubMed ID: 29117481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.